Codes / ICD10CM / H91.09

H91.09 Ototoxic hearing loss, unspecified ear

ICD10CM code

ICD10CM

Chat with GenHealth to automate any coding or chart task.

Name of the Condition

  • Ototoxic hearing loss, unspecified ear

Summary

Ototoxic hearing loss, unspecified ear, is a hearing impairment caused by exposure to substances that damage the inner ear, resulting in temporary or permanent hearing loss in one or both ears (when the specific ear is not documented). This condition may also involve balance disturbances if the vestibular system is affected.

Causes

Ototoxic hearing loss occurs due to the toxic effects of specific medications or chemicals on the auditory system. Common causes include certain antibiotics (e.g., aminoglycosides), chemotherapy drugs (e.g., cisplatin), high doses of aspirin, and exposure to solvents or heavy metals. These substances typically damage the hair cells in the cochlea, which are essential for hearing.

Risk Factors

  • Prolonged or high-dose use of ototoxic medications.
  • Pre-existing kidney or liver dysfunction, which can impair drug metabolism.
  • Genetic susceptibility to ototoxicity.
  • Concurrent use of multiple ototoxic agents.
  • Exposure to loud noise while taking ototoxic drugs, as this may exacerbate damage.

Symptoms

  • Gradual or sudden hearing loss in one or both ears (when the specific ear is not documented).
  • Tinnitus (ringing or buzzing in the ears).
  • Difficulty understanding speech, especially in noisy environments.
  • Balance problems or dizziness (if the vestibular system is involved).
  • A feeling of fullness or pressure in the ears.

Diagnosis

Diagnosis involves a thorough patient history to identify potential ototoxic exposures, followed by audiometric testing to assess hearing function. Additional evaluations, such as vestibular testing or imaging, may be performed if balance issues are present. The unspecified ear designation is used when the specific ear affected is not documented in the medical record.

Treatment Options

Treatment focuses on discontinuing or adjusting the ototoxic agent when possible, along with managing symptoms. Hearing aids or cochlear implants may be considered for permanent hearing loss. Vestibular rehabilitation may help with balance issues. Monitoring for recovery or progression is essential.

Prognosis and Follow-Up

Prognosis depends on the extent of inner ear damage and the reversibility of the ototoxic agent. Some cases may resolve with discontinuation of the offending substance, while others result in permanent hearing loss. Regular follow-up with audiologic assessments is recommended to track changes and adjust management.

Complications

Potential complications include permanent hearing loss, persistent tinnitus, and chronic balance disorders. Untreated or progressive hearing loss may impact communication and quality of life.

Lifestyle & Prevention

  • Avoid or limit exposure to known ototoxic substances when possible.
  • Use protective measures (e.g., noise reduction) if exposed to loud environments while on ototoxic medications.
  • Maintain regular hearing check-ups, especially when taking ototoxic drugs.
  • Discuss alternative medications with healthcare providers if ototoxicity is a concern.

When to Seek Professional Help

Seek medical attention if you experience sudden or worsening hearing loss, tinnitus, or balance problems, particularly after starting a new medication or exposure to chemicals. Prompt evaluation can help mitigate further damage.

Tips for Medical Coders

Use H91.09 for ototoxic hearing loss when the specific ear is not documented. Ensure the medical record supports the diagnosis and absence of ear specification. Document any relevant ototoxic exposures or contributing factors to support coding accuracy.

Book a walkthrough

H91.09 policy automation walkthrough

Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.